Yosef Yarden

14PUBLICATIONS
104CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Diana Drago-Garcia, Suvendu Giri, Rishita Chatterjee

|Nov 28, 2022
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.

Yael Aylon, Noa Furth, Giuseppe Mallel

|Jul 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee

|May 19, 2022
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.

Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked

|Apr 19, 2022
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.

Saptaparna Mukherjee, Martino Maddalena, YiQing Lü

Pageof 3

Frequent Collaborators

10 joint publications

Yosef Yarden

8 joint publications

Moshe Oren

5 joint publications

Stefan Wiemann

5 joint publications

Yael Aylon